Cargando…
Do men with bladder stones benefit from treatment of benign prostatic obstruction?
OBJECTIVE: To identify whether men aged ≥40 years with bladder stones (BS) benefit from treatment of benign prostatic obstruction (BPO). PATIENTS AND METHODS: A regional, retrospective study of patients undergoing BS surgery between January 2011 and December 2018 was performed using a prospectively...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790555/ https://www.ncbi.nlm.nih.gov/pubmed/35482471 http://dx.doi.org/10.1111/bju.15761 |
_version_ | 1784859204101603328 |
---|---|
author | Maresca, Gianluca Mc Clinton, Samuel Swami, Satchi El‐Mokadem, Ismail Donaldson, James F. |
author_facet | Maresca, Gianluca Mc Clinton, Samuel Swami, Satchi El‐Mokadem, Ismail Donaldson, James F. |
author_sort | Maresca, Gianluca |
collection | PubMed |
description | OBJECTIVE: To identify whether men aged ≥40 years with bladder stones (BS) benefit from treatment of benign prostatic obstruction (BPO). PATIENTS AND METHODS: A regional, retrospective study of patients undergoing BS surgery between January 2011 and December 2018 was performed using a prospectively collected database. The primary outcome was BS recurrence after successful removal. Kruskal–Wallis and chi‐squared statistical tests were used. RESULTS: A total of 174 patients underwent BS removal and 71 (40.8%) were excluded due to BS formation secondary to causes other than BPO. Hence, 103 men aged ≥40 years had BS successfully removed, of which 40% had a history of upper tract urolithiasis. These men were divided into three groups: those undergoing contemporaneous medical, surgical, or no BPO treatment. Age, diabetes, previous urolithiasis and previous BPO surgery were well matched between the BPO treatment groups. In all, 18 of these men (17%) had BS recurrence after 46 months follow‐up. Recurrences were significantly lower following BPO surgery; one of 34 (3%) men versus five of 28 (18%) with no BPO treatment (P = 0.048) and 12 of 41 (29%) with medical BPO treatment (P = 0.003). Recurrences after medical and no BPO treatment were similar (P = 0.280). In all, 34 men (33%) had BPO complications that were similar between groups (P = 0.378). CONCLUSION: This is the largest reported cohort of men, with the longest follow‐up after BS removal. Most men aged ≥40 years with BS benefit from BPO surgery. However, the study findings also support a multifactorial aetiology for BS, which questions the dogma that BS are an ‘absolute indication’ for BPO surgery, as is stated in the Non‐neurogenic Male Lower Urinary Tract Symptoms European Association of Urology Guideline. Assessment and management of all causative factors is likely to enable selection of which men will benefit from BPO surgery and to reduce BS recurrence rates. |
format | Online Article Text |
id | pubmed-9790555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97905552022-12-28 Do men with bladder stones benefit from treatment of benign prostatic obstruction? Maresca, Gianluca Mc Clinton, Samuel Swami, Satchi El‐Mokadem, Ismail Donaldson, James F. BJU Int Original Articles OBJECTIVE: To identify whether men aged ≥40 years with bladder stones (BS) benefit from treatment of benign prostatic obstruction (BPO). PATIENTS AND METHODS: A regional, retrospective study of patients undergoing BS surgery between January 2011 and December 2018 was performed using a prospectively collected database. The primary outcome was BS recurrence after successful removal. Kruskal–Wallis and chi‐squared statistical tests were used. RESULTS: A total of 174 patients underwent BS removal and 71 (40.8%) were excluded due to BS formation secondary to causes other than BPO. Hence, 103 men aged ≥40 years had BS successfully removed, of which 40% had a history of upper tract urolithiasis. These men were divided into three groups: those undergoing contemporaneous medical, surgical, or no BPO treatment. Age, diabetes, previous urolithiasis and previous BPO surgery were well matched between the BPO treatment groups. In all, 18 of these men (17%) had BS recurrence after 46 months follow‐up. Recurrences were significantly lower following BPO surgery; one of 34 (3%) men versus five of 28 (18%) with no BPO treatment (P = 0.048) and 12 of 41 (29%) with medical BPO treatment (P = 0.003). Recurrences after medical and no BPO treatment were similar (P = 0.280). In all, 34 men (33%) had BPO complications that were similar between groups (P = 0.378). CONCLUSION: This is the largest reported cohort of men, with the longest follow‐up after BS removal. Most men aged ≥40 years with BS benefit from BPO surgery. However, the study findings also support a multifactorial aetiology for BS, which questions the dogma that BS are an ‘absolute indication’ for BPO surgery, as is stated in the Non‐neurogenic Male Lower Urinary Tract Symptoms European Association of Urology Guideline. Assessment and management of all causative factors is likely to enable selection of which men will benefit from BPO surgery and to reduce BS recurrence rates. John Wiley and Sons Inc. 2022-05-17 2022-11 /pmc/articles/PMC9790555/ /pubmed/35482471 http://dx.doi.org/10.1111/bju.15761 Text en © 2022 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Maresca, Gianluca Mc Clinton, Samuel Swami, Satchi El‐Mokadem, Ismail Donaldson, James F. Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title | Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title_full | Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title_fullStr | Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title_full_unstemmed | Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title_short | Do men with bladder stones benefit from treatment of benign prostatic obstruction? |
title_sort | do men with bladder stones benefit from treatment of benign prostatic obstruction? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790555/ https://www.ncbi.nlm.nih.gov/pubmed/35482471 http://dx.doi.org/10.1111/bju.15761 |
work_keys_str_mv | AT marescagianluca domenwithbladderstonesbenefitfromtreatmentofbenignprostaticobstruction AT mcclintonsamuel domenwithbladderstonesbenefitfromtreatmentofbenignprostaticobstruction AT swamisatchi domenwithbladderstonesbenefitfromtreatmentofbenignprostaticobstruction AT elmokademismail domenwithbladderstonesbenefitfromtreatmentofbenignprostaticobstruction AT donaldsonjamesf domenwithbladderstonesbenefitfromtreatmentofbenignprostaticobstruction |